NCT01932112View on ClinicalTrials.gov

Adenosine Effect on Persistent Pulmonary Vein Isolation Line Evaluation (APPLE Trial)

PHASE3CompletedINTERVENTIONAL
Enrollment

378

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2015

Study Completion Date

May 31, 2015

Conditions
Atrial FibrillationPersistent Common Pulmonary Vein
Interventions
DRUG

Adenosine arm

After pulmonary vein isolation,20mg Intracardiac adenosine will be given to treatment group, will evaluate pulmonary vein reconnection.

Trial Locations (1)

137-040

Seoul st Mary's Hospital, Seoul

All Listed Sponsors
lead

Yong Seog Oh

OTHER

NCT01932112 - Adenosine Effect on Persistent Pulmonary Vein Isolation Line Evaluation (APPLE Trial) | Biotech Hunter | Biotech Hunter